Investor Relations

Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.

Latest News

Half year trading update
22 October 2019

Director/PDMR Shareholding
26 September 2019

Result of AGM
20 September 2019

Share Price

Fusion Antibodies Company Profile

Read More »

Who We Are

Investor Videos

Watch latest video »

Investor Alert

Sign up for Investor Alerts »
close menu